Advertisement
Loading...

Galapagos N.V. Sponsored ADR

LKFTNASDAQ
Healthcare
Biotechnology
$27.92
$-0.40(-1.41%)
U.S. Market is Open • 13:29
Advertisement

Galapagos N.V. Sponsored ADR (LKFT) Stock Overview

Explore Galapagos N.V. Sponsored ADR’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio3.28
EPS (TTM)$8.62
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

LKFT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Galapagos N.V. Sponsored ADR (LKFT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 3.28 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.11%
5-Day Change
2.35%
1-Month Change
1.76%
3-Month Change
-0.74%
6-Month Change
-0.74%
Year-to-Date (YTD) Change
-0.74%
1-Year Change
-0.74%
3-Year Change
-0.74%
5-Year Change
-0.74%
All-Time (Max) Change
-0.74%

Contact Information

32 1 534 29 00
SchaliEnhoevedreef 20 T, Mechelen, NaN, 2800

Company Facts

452 Employees
IPO DateMay 5, 2005
CountryUS
Actively Trading

Frequently Asked Questions